Madrigal Pharmaceuticals Price Target Announced at $725.00/Share by Citigroup
Ratings actions from Benzinga: GMT) Madrigal Pharmaceuticals Initiated at Buy by CitigroupRatings actions from Benzinga
Related stories
Duffy: Passengers will still face some delays and cancellations as airlines adjust flights and move crews where most needed
L impact | NEWS | Nov 14, 2026, 01:51 PM UTC
Duffy: close coordination with airlines to back ongoing recovery
L impact | NEWS | Nov 14, 2026, 01:51 PM UTC
Saudi-led coalition: intercepts and destroys two drones launched by Yemen's Houthis toward Riyadh and southern region
L impact | NEWS | Nov 14, 2026, 01:07 PM UTC
Italy’s data protection authority fines Meta Platforms €805 million over alleged use of videos and photos of Android users without consent
L impact | NEWS | Nov 14, 2026, 12:18 PM UTC
Kraken: probing problem with Osmosis funding gateway, deposits and withdrawals might be postponed
L impact | NEWS | Nov 14, 2026, 11:06 AM UTC
Russian defence ministry: struck Ukrainian energy and transport infrastructure used by military, drone production and storage facilities
L impact | NEWS | Nov 14, 2026, 09:06 AM UTC